Sign Up
Stories
White House Pharmacy Misconduct Allegations
Share
Censorship of Vaccine Victims
Birx's Unveiled Influence: Pandemic Fall...
CDC Concealed Vaccine Reactions
Collins Regrets Narrow Covid Approach
Overview
API
White House pharmacy under the Trump administration faced improper drug provisioning and misuse of funds, according to a Pentagon report. The pharmacy failed to comply with federal guidelines, providing prescription drugs to ineligible staffers and using excessive amounts of expensive brand-name medications. The report highlighted risks to patient health and safety, covering the period from 2009 to 2018, focusing on the 2017-2019 administration under Trump.
Ask a question
How might this misconduct impact public trust in the White House's medical operations?
What broader implications does this have for the governance and ethics of pharmacies in the US?
What measures can be implemented to ensure compliance with federal guidelines in pharmacies?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Coverage